Table 3. Anthropometric, and biochemical features of patients with metabolic syndrome.
Metabolic indices |
Measurements |
MetS N=61 |
Control N=30 |
P-value |
WC (cm) |
mean ± SD |
107.4 ± 12.45 |
91.3 ± 11.2 |
0.000* |
BMI (kg/m2) |
mean ± SD |
30.48 ± 4.6 |
27.25 ± 3.9 |
0.001* |
TC (mg/dl) |
mean ± SD |
182.2 ± 46.9 |
133.1 ± 60.4 |
0.000* |
TG (mg/dl) |
Median (IQR) |
160(118-205.5) |
98(98-141.7) |
0.000* |
HDL (mg/dl) |
mean ± SD |
56.2 ± 14.02 |
48.3 ± 8.4 |
0.001* |
LDL (mg/dl) |
Median (IQR) |
97(53-112.8) |
55(53-110.5) |
0.003* |
VLDL (mg/dl) |
Median (IQR) |
32(23.6-41.1) |
19(19-28.4) |
0.000* |
SBP (mmHg) |
Median (IQR) |
130(120-150) |
120(120-130) |
0.001* |
DBP (mmHg) |
Median (IQR) |
90(80-97) |
80(80-80) |
0.000* |
HbA1c (%) |
Median (IQR) |
6.5(5.9-7.3) |
5.8(5-6) |
0.000* |
FBG (mg/dl) |
Median (IQR) |
113(100-132) |
102(89.5-112.3) |
0.013* |
The 2-tailed standard t test was used for comparisons of means. The “Mann-Whitney U Test” was used for comparisons of median. MetS, metabolic syndrome patients. * Statistically significant. WC, waist circumference. TC, total cholesterol.TG, triglyceride. HDL, high density lipoprotein. LDL, low density lipoprotein. VLDL, very low-density lipoprotein. SBP, systolic blood pressure. DBP, diastolic blood pressure. HbA1c, Hemoglobin A1c. FBG, Fasting blood glucose.